Cellectis (CLLS) Gross Margin (QoQ) (2015 - 2023)

Cellectis (CLLS) Gross Margin (QoQ) (2015 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cellectis 281.48 Mn 95.81 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 35,833.00
Sep 30, 2023 -20,588.00
Jun 30, 2023 20,939.00
Mar 31, 2023 -14,055.00
Dec 31, 2022 10,998.00
Sep 30, 2022 -18,454.00
Jun 30, 2022 7,291.00
Mar 31, 2022 252.00
Dec 31, 2021 1,025.00
Sep 30, 2021 -567.00
Jun 30, 2021 398.00
Mar 31, 2021 2,744.00
Dec 31, 2020 -1,004.00
Sep 30, 2020 7,437.00
Jun 30, 2020 -19,175.00
Mar 31, 2020 11,861.00
Dec 31, 2019 -7,764.00
Sep 30, 2019 2,060.00
Jun 30, 2019 -1,418.00
Mar 31, 2019 1,782.00